Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion ...
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
Extending Distributed Generation Permissive (DGP) technology to 69kV sub-transmission enables dependable islanding protection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results